Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Goal:
The goal of this observational study is to evaluate the genotoxic and cytotoxic effects of OPG and CBCT on exfoliated buccal mucosal cells
Main question:
Does CBCT cause greater genotoxic and cytotoxic effects on buccal mucosal cells compared with OPG? Buccal epithelial cells were gently exfoliated from participants scheduled to undergo OPG or CBCT imaging. Samples were collected twice-immediately before exposure and again 10-12 days afterward. All participants provided written informed consent prior to inclusion in the study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| OPG,15-25 years old | |||
| CBCT,15-25 years old | |||
| OPG,40-50 years old | |||
| CBCT,40-50 years old |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Primary outcome: Change in micronucleated buccal epithelial cells measured by the Buccal Micronucleus Cytome Assay (MN per 2,000 cells) | Micronucleated buccal epithelial cells will be quantified using the Buccal Micronucleus Cytome Assay following Sarto et al. (1987) criteria. For each participant, 2,000 exfoliated buccal cells will be evaluated at two time points:
The primary analysis will report the change in the number of micronucleated cells per 2,000 cells (post-pre difference). Micronuclei are identified based on size, morphology, staining characteristics, and separation from the main nucleus. Higher post-pre values indicate greater genotoxic response. | 10 ±12 days after exposure |
Not provided
Not provided
Inclusion Criteria:
Underwent routine dental imaging using OPG or CBCT (no additional radiation for research purposes).
Age 15-25 years or 40-50 years at the time of enrolment.
Able and willing to provide written informed consent (or consent from a legal guardian for minors).
Agreed to provide pre-exposure and follow-up buccal epithelial cell samples.
Exclusion Criteria:
History of systemic diseases, including but not limited to leukemia, lymphoma, rheumatic disorders, or diabetes mellitus.
Prior exposure to head-and-neck radiotherapy, immunosuppressive drugs, or cytotoxic medications.
Presence of active infectious diseases or acute/chronic inflammatory conditions at the time of enrolment.
Clinically visible oral pathological lesions, including mucosal abnormalities, gingivitis, or periodontitis.
Use of removable intra-oral prostheses or appliances (e.g., dentures, orthodontic appliances).
Engagement in smoking, alcohol consumption, or betel-nut chewing.
Diagnostic or therapeutic X-ray exposure within the preceding 3 months.
Previous or current oral mucosal diseases, including oral lichen planus, recurrent aphthous stomatitis, oral candidiasis, HSV infection, leukoplakia, oropharyngeal carcinoma, mucous membrane pemphigoid, or pemphigus vulgaris.
Presence of persistent local irritants, including ill-fitting dental prostheses, sharp teeth/restorations, chemical irritation (acidic foods, alcohol-based mouthwash), or recurrent thermal injury.
Not provided
Not provided
Adults aged 15-25 years and 40-50 years undergoing routine dental radiographic examination (OPG or CBCT), with follow-up buccal cell sampling for cytogenetic analysis.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| universiti Sains Malaysia hospital | Kota Bharu | Kelantan | 25000 | Malaysia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided